These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 10404877)

  • 1. Quality control of bovine serum used for vaccine production.
    Mareschal JC
    Dev Biol Stand; 1999; 99():61-8. PubMed ID: 10404877
    [No Abstract]   [Full Text] [Related]  

  • 2. Benefits and risks due to animal serum used in cell culture production.
    Wessman SJ; Levings RL
    Dev Biol Stand; 1999; 99():3-8. PubMed ID: 10404869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bovine serum: reducing the variables through the use of donor herds.
    Rolleston WB
    Dev Biol Stand; 1999; 99():79-86. PubMed ID: 10404879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why do we still use serum in the production of biopharmaceuticals?
    Shah G
    Dev Biol Stand; 1999; 99():17-22. PubMed ID: 10404871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bovine polyomavirus, a frequent contaminant of calf sera.
    van der Noordaa J; Sol CJ; Schuurman R
    Dev Biol Stand; 1999; 99():45-7. PubMed ID: 10404875
    [No Abstract]   [Full Text] [Related]  

  • 6. Detecting viruses in sera: methods used and their merits.
    Jennings A
    Dev Biol Stand; 1999; 99():51-9. PubMed ID: 10404876
    [No Abstract]   [Full Text] [Related]  

  • 7. Elimination of serum from cell culture medium.
    Lubiniecki AS
    Dev Biol Stand; 1999; 99():153-6. PubMed ID: 10404886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal-free culture process for manufacture of viral vaccines: process validation and regulatory perspectives.
    Pierard I; Mareschal JC; Gonze MM; Duchêne M
    Dev Biol (Basel); 2006; 123():283-90; discussion 291-308. PubMed ID: 16566454
    [No Abstract]   [Full Text] [Related]  

  • 9. Risks of virus transmission associated with animal sera or substitutes and methods of control.
    Eloit M
    Dev Biol Stand; 1999; 99():9-16. PubMed ID: 10404870
    [No Abstract]   [Full Text] [Related]  

  • 10. Summary and conclusion. Animal sera, animal sera derivatives and substitutes used in the manufacture of pharmaceuticals.
    Castle P; Robertson JS
    Dev Biol Stand; 1999; 99():191-6. PubMed ID: 10404890
    [No Abstract]   [Full Text] [Related]  

  • 11. WHO requirements for the use of animal cells as in vitro substrates for the production of biologicals: application to influenza vaccine production.
    Griffiths E
    Dev Biol Stand; 1999; 98():153-7; discussion 167. PubMed ID: 10494968
    [No Abstract]   [Full Text] [Related]  

  • 12. Quality of biotechnological products: derivation and characterisation of cell substrates used for production of biotechnological/biological products. ICH Harmonised Tripartite Guideline.
    Dev Biol Stand; 1998; 93():223-34. PubMed ID: 9737399
    [No Abstract]   [Full Text] [Related]  

  • 13. An overview of animal cell substrates for biological products.
    Petricciani J; Sheets R
    Biologicals; 2008 Nov; 36(6):359-62. PubMed ID: 18674929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral safety of biological products in WHO policy.
    Grachev VP
    Dev Biol Stand; 1991; 75():241-6. PubMed ID: 1794628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of biotechnological products: analysis of the expression construct in cell lines used for production of r-DNA derived protein products. ICH Harmonised Tripartite Guideline.
    Dev Biol Stand; 1998; 93():205-8. PubMed ID: 9737397
    [No Abstract]   [Full Text] [Related]  

  • 16. Gamma irradiation of bovine sera.
    Plavsic MZ; Daley JP; Danner DJ; Weppner DJ
    Dev Biol Stand; 1999; 99():95-109. PubMed ID: 10404881
    [No Abstract]   [Full Text] [Related]  

  • 17. WHO Expert Committee on Biological Standardization. Forty-sixth Report.
    World Health Organ Tech Rep Ser; 1998; 872():i-vii, 1-90. PubMed ID: 9615608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient inactivation of viruses and mycoplasma in animal sera using UVC irradiation.
    Kurth J; Waldmann R; Heith J; Mausbach K; Burian R
    Dev Biol Stand; 1999; 99():111-8. PubMed ID: 10404882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of biotechnological products: viral safety evaluation of biotechnology products derived from cell lines of human or animal origin. ICH Harmonised Tripartite Guideline.
    Dev Biol Stand; 1998; 93():177-201. PubMed ID: 9737396
    [No Abstract]   [Full Text] [Related]  

  • 20. WHO Expert Committee on Biological Standardization.
    World Health Organ Tech Rep Ser; 2002; 910():1-104, back cover. PubMed ID: 15497598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.